Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2017 07:00 ET | Source: MediWound Ltd.

MediWound Reports First Quarter 2017 Financial Results

YAVNE, Israel, May 08, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
May 03, 2017 07:00 ET | Source: MediWound Ltd.

MediWound Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health

YAVNE, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
May 01, 2017 07:00 ET | Source: MediWound Ltd.

MediWound to Host First Quarter 2017 Financial Results Conference Call on May 8, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, May 01, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
March 30, 2017 08:59 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® and EscharEx® to be Highlighted in Multiple Presentations at the Symposium on Advanced Wound Care Spring

YAVNE, Israel, March 30, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
March 17, 2017 13:21 ET | Source: MediWound Ltd.

MediWound Announces Conference Call and Webcast of “Meet the Experts” Panel Discussion Chaired by SunTrust Robinson Humphrey at the 49th American Burn Association Annual Meeting

YAVNE, Israel, March 17, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe...
March 14, 2017 07:00 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® and EscharEx® to be Highlighted in Presentations at the American Burn Association 49th Annual Meeting

YAVNE, Israel, March 14, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
March 13, 2017 07:00 ET | Source: MediWound Ltd.

MediWound to Present at the Oppenheimer 27th Annual Healthcare Conference

YAVNE, Israel, March 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
March 03, 2017 07:00 ET | Source: MediWound Ltd.

Cost Analysis Demonstrating Significant Health Care Savings Utilizing NexoBrid® in Burn Management Published in BioMed Research International

YAVNE, Israel, March 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
February 21, 2017 07:00 ET | Source: MediWound Ltd.

MediWound Reports 2016 Fourth Quarter and Full Year Financial Results

YAVNE, Israel, Feb. 21, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
February 14, 2017 07:00 ET | Source: MediWound Ltd.

MediWound to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on February 21, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, Feb. 14, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...